Integral Health Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-40,000
Closed -$12.5M 67
2024
Q2
$12.5M Buy
+40,000
New +$11.8M 1.19% 29
2023
Q4
Sell
-65,000
Closed -$17.5M 71
2023
Q3
$17.5M Buy
+65,000
New +$16.2M 2.42% 12
2020
Q3
Sell
-25,000
Closed -$5.9M 75
2020
Q2
$5.9M Buy
+25,000
New +$5.7M 1.77% 25

Other funds holding AMGN

Integral Health Asset Management's AMGN Position: Q3 2024 in Review

Integral Health Asset Management sold out of Amgen (AMGN) in Q3 2024, closing a stake of 40,000 shares — an estimated $12.5M sold.

Integral Health Asset Management first reported a position in AMGN in Q2 2020 and held it in 3 quarters. The position peaked at $17.5M in Q3 2023. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Integral Health Asset Management reported no remaining Amgen position as of Q3 2024 after selling out during the quarter.
  • Integral Health Asset Management sold 40,000 Amgen shares in Q3 2024, an estimated $12.5M.
  • Integral Health Asset Management first reported a position in Amgen in Q2 2020 and held it in 3 quarters.
  • Integral Health Asset Management's Amgen position peaked at $17.5M in Q3 2023.
  • 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Integral Health Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.